Skip to main content
Caplight Logo









EOC Pharma

EOC Pharma

Private
ShanghaiHealthcare & Life Scienceshttps://eocpharma.com

Last Round

Series C

Dec 2, 2019

Total Funding Raised

$103.1M

Company Overview

EOC Pharma operates in Healthcare & Life Sciences and is based in Shanghai. Its latest recorded funding round was a Series C round in December 2019.

EOC Pharma is a biopharmaceutical company that focuses on the discovery, research, development, and commercialization of innovative oncology products for the Chinese market.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

EOC Pharma Comparables

Compare EOC Pharma with similar companies based on industry and business-model similarity.

EOC Pharma comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Xynomic Pharmaceuticals
84%
Zai Lab Limited
81%
Genor BioPharma
77%
Book a demo to see all comparables

For institutional investors. Book with your work email.

EOC Pharma Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series CDec 2, 2019
Series BNov 7, 2017
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

EOC Pharma Investors

Notable investors and investment history

EOC Pharma investors
InvestorRounds
TF CapitalSeries C
H&Q Asia PacificSeries B
Yingke PESeries C
HongShan Capital Group (HSG)Series B, Series A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 2, 2026

    Monthly visitors grew 190% MoM, from 415 to 1.2K.

Book a demo to see all signals

For institutional investors. Book with your work email.

EOC Pharma Filings

Explore SEC and related filing metadata, where available.

EOC Pharma filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about EOC Pharma's valuation, stock price, and market status.

Is EOC Pharma a public or private company?

EOC Pharma is a private company.

What is the current stock price of EOC Pharma?

EOC Pharma is a private company, so its shares have no public market price. Caplight tracks EOC Pharma's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is EOC Pharma worth (valuation)?

Valuation information for EOC Pharma is not publicly available.

Can I buy EOC Pharma stock?

EOC Pharma shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was EOC Pharma's last funding round?

EOC Pharma's most recent funding round was Series C on December 2, 2019.

Who are the main investors in EOC Pharma?

Key investors in EOC Pharma include TF Capital, Yingke PE, HongShan Capital Group (HSG).

Will EOC Pharma IPO soon?

No public IPO plans have been announced for EOC Pharma.

How can I track EOC Pharma secondary market activity?

Caplight tracks bids, offers, and trades in EOC Pharma's shares on secondary markets.

Firmographic Details

HeadquartersShanghai
Employee Range3
Year Founded2015
Last FundingDec 2, 2019

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?